ActivePhase 3ACTRN12618000879268

Targeted Oxygenation in the Respiratory care of Premature Infants at Delivery: Effects on Outcome (TORPIDO 30/60)

Lower or higher initial oxygen concentration with Targeted Oxygen saturation in Respiratory care of premature Infants at Delivery: effects on Outcome (TORPIDO 30/60)


Sponsor

University of Sydney

Enrollment

1,470 participants

Start Date

Sep 13, 2018

Study Type

Interventional

Conditions

Summary

Premature infants usually need extra oxygen after birth because their lungs are not fully developed. However, their bodies do not yet have the ability to balance the stress that receiving that oxygen can cause. Oxygen is necessary for life, but both too much or too little can damage eyes, lungs, brain and other important organs of newborn babies. This study will compare outcomes of 1470 preterm infants up to 28/6 weeks gestation who have had respiratory care in the delivery room with (A) Initial FiO2 0.6 versus (B) Initial FiO2 0.3, followed by common SpO2 targeting until admission to NICU. FiO2, SpO2, and heart rate are recorded each minute from delivery of the child’s body for 10 minutes, then every 5 minutes until admission to NICU. Routine assessments are collected at baseline, 36 weeks, discharge and at 2 years corrected for gestation. Additionally a parent-completed developmental questionnaire is also collected at 2 years corrected for gestation.


Eligibility

Sex: Both males and femalesMin Age: 23 WeekssMax Age: 29 Weekss

Inclusion Criteria1

  • Premature infants born from 23/0 to 28/6 weeks gestation

Exclusion Criteria1

  • Any known major cardiopulmonary abnormalities that could affect oxygenation or congenital malformations that could affect neuro-developmental outcome or survival

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

At delivery, a CPAP mask will be applied by the caregiver (e.g. midwife, neonatal clinician, obstetrician, anaesthetist), and initial FiO2 level will be set to 0.6. Using a pulse oximeter, FiO2 will b

At delivery, a CPAP mask will be applied by the caregiver (e.g. midwife, neonatal clinician, obstetrician, anaesthetist), and initial FiO2 level will be set to 0.6. Using a pulse oximeter, FiO2 will be adjusted as required to achieve target SpO2 (80-85% at 5 min and 85-95% at 10 min and thereafter), until admission to the NICU.


Locations(13)

The Canberra Hospital - Garran

ACT,NSW,NT,QLD,SA,VIC, Australia

Royal Prince Alfred Hospital - Camperdown

ACT,NSW,NT,QLD,SA,VIC, Australia

Royal Hospital for Women - Randwick

ACT,NSW,NT,QLD,SA,VIC, Australia

Gold Coast Hospital - Southport

ACT,NSW,NT,QLD,SA,VIC, Australia

Flinders Medical Centre - Bedford Park

ACT,NSW,NT,QLD,SA,VIC, Australia

Royal Darwin Hospital - Tiwi

ACT,NSW,NT,QLD,SA,VIC, Australia

John Hunter Hospital - New Lambton

ACT,NSW,NT,QLD,SA,VIC, Australia

Westmead Hospital - Westmead

ACT,NSW,NT,QLD,SA,VIC, Australia

Bangalore, India

Kuala Lumpur, Malaysia

Bukit Timah, Singapore

New Jersey, United States of America

Madrid, Spain

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12618000879268